Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New measurable indicator for tuberculosis case detection.

Martien W Borgdorff1

  • 1KNCV Tuberculosis Foundation, The Hague, the Netherlands. borgdorffm@kncvtbc.nl

Emerging Infectious Diseases
|October 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculosis disease and infection among household contacts of bacteriologically confirmed and non-confirmed tuberculosis patients.

Tropical medicine & international health : TM & IH·2020
Same author

Decreased HIV-associated mortality rates during scale-up of antiretroviral therapy, 2011-2016.

AIDS (London, England)·2019
Same author

High yield of new HIV diagnoses during active case-finding for tuberculosis.

AIDS (London, England)·2019
Same author

Investigations of Foodborne Diseases by Food Inspection Services in The Netherlands, 1991 to 1994.

Journal of food protection·2019
Same author

Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western Kenya.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2019
Same author

Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.

BMC infectious diseases·2018

This study introduces the patient diagnostic rate, a new metric for tuberculosis (TB) case detection. This method offers a more reliable way to measure TB control program effectiveness by using prevalence data.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Control

Background:

  • The World Health Organization (WHO) aims for 70% case detection and 85% cure rates for new, smear-positive tuberculosis (TB) cases.
  • Current TB case detection rates rely on estimated incidence, introducing uncertainty due to the lack of direct TB incidence measurement.
  • The unreliability of incidence estimates impacts the accurate assessment of TB control program performance.

Purpose of the Study:

  • To propose a novel indicator, the patient diagnostic rate, for evaluating TB case detection.
  • To offer a more accurate and measurable alternative to the traditional case detection rate.
  • To enhance the assessment of TB control program effectiveness in diverse settings.

Main Methods:

  • Introduced the patient diagnostic rate: reported cases per 100,000 population divided by prevalence per 100,000.

Related Experiment Videos

  • Highlighted that prevalence can be directly measured through national surveys.
  • Recommended conducting national prevalence surveys every 5-10 years for ongoing assessment.

    • Main Results:

    • The patient diagnostic rate provides a direct measure of how effectively prevalent TB cases are identified by control programs.
    • This new metric addresses the uncertainty associated with using estimated incidence rates.
    • It allows for a more precise evaluation of TB control efforts, particularly in high-burden countries.

    Conclusions:

    • The patient diagnostic rate is a more robust indicator for assessing TB case detection performance.
    • Regular national prevalence surveys are crucial for implementing and utilizing this new metric effectively.
    • This approach can significantly improve the monitoring and impact assessment of global TB control strategies.